U.S. Physical Therapy Stock Price, News & Analysis (NYSE:USPH)

$76.80 0.70 (0.92 %)
(As of 01/21/2018 03:57 AM ET)
Previous Close$76.80
Today's Range$75.65 - $76.80
52-Week Range$56.50 - $78.00
Volume27,354 shs
Average Volume33,098 shs
Market Capitalization$957.43 million
P/E Ratio46.27
Dividend Yield1.05%
Beta1.09

About U.S. Physical Therapy (NYSE:USPH)

U.S. Physical Therapy logoU.S. Physical Therapy, Inc., through its subsidiaries, operates outpatient physical therapy clinics that provide pre-and post-operative care, and treatment for orthopedic-related disorders, sports-related injuries, preventative care, rehabilitation of injured workers and neurological-related injuries. The Company's segment is made up of various clinics within partnerships. The Company primarily operates through subsidiary clinic partnerships, in which it owns a general partnership interest and a limited partnership interest, and the managing therapists of the clinics owns the remaining limited partnership interest in the clinics. The Company operates 562 physical therapy clinics in 42 states. There are approximately 380 clinics operated under Clinic Partnerships and over 100 operated as Company-owned Facilities. In addition to its owned clinics, it also manages physical therapy facilities for third parties, primarily physicians, with over 29 third-party facilities under management.

Receive USPH News and Ratings via Email

Sign-up to receive the latest news and ratings for USPH and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry Hospitals, Clinics & Primary Care Services
Sub-IndustryHealth Care Facilities
SectorMedical
SymbolNYSE:USPH
CUSIP90337L10
Phone713-297-7000

Debt

Debt-to-Equity Ratio0.30%
Current Ratio2.04%
Quick Ratio2.04%

Price-To-Earnings

Trailing P/E Ratio46.265338947825
Forward P/E Ratio37.10
P/E Growth2.81

Sales & Book Value

Annual Sales$356.55 million
Price / Sales2.71
Cash Flow$2.66 per share
Price / Cash28.82
Book Value$15.07 per share
Price / Book5.10

Profitability

Trailing EPS$1.66
Net Income$20.55 million
Net Margins5.29%
Return on Equity13.37%
Return on Assets6.63%

Miscellaneous

Employees3,800
Outstanding Shares12,580,000

U.S. Physical Therapy (NYSE:USPH) Frequently Asked Questions

What is U.S. Physical Therapy's stock symbol?

U.S. Physical Therapy trades on the New York Stock Exchange (NYSE) under the ticker symbol "USPH."

How often does U.S. Physical Therapy pay dividends? What is the dividend yield for U.S. Physical Therapy?

U.S. Physical Therapy declared a quarterly dividend on Tuesday, October 31st. Shareholders of record on Friday, November 17th will be given a dividend of $0.20 per share on Friday, December 8th. This represents a $0.80 dividend on an annualized basis and a yield of 1.04%. The ex-dividend date is Thursday, November 16th. View U.S. Physical Therapy's Dividend History.

How were U.S. Physical Therapy's earnings last quarter?

U.S. Physical Therapy, Inc. (NYSE:USPH) announced its earnings results on Thursday, November, 2nd. The company reported $0.48 EPS for the quarter, missing the Thomson Reuters' consensus estimate of $0.52 by $0.04. The business earned $103.03 million during the quarter, compared to analyst estimates of $102.69 million. U.S. Physical Therapy had a return on equity of 13.37% and a net margin of 5.29%. View U.S. Physical Therapy's Earnings History.

Where is U.S. Physical Therapy's stock going? Where will U.S. Physical Therapy's stock price be in 2018?

4 equities research analysts have issued 1 year price targets for U.S. Physical Therapy's stock. Their forecasts range from $65.00 to $80.00. On average, they anticipate U.S. Physical Therapy's share price to reach $71.75 in the next twelve months. View Analyst Ratings for U.S. Physical Therapy.

What are Wall Street analysts saying about U.S. Physical Therapy stock?

Here are some recent quotes from research analysts about U.S. Physical Therapy stock:

  • 1. Cantor Fitzgerald analysts commented, "After today’s market close, USPH released its preliminary estimates for the company’s 2018 consolidated tax rate; it estimates its effective rate will be within a range of 26-29%." (1/9/2018)
  • 2. According to Zacks Investment Research, "U.S. Physical Therapy, Inc. is the largest publicly-traded, pure-play operator of outpatient physical and occupational therapy clinics, with over 500 Clinics in 42 States. The clinics provide pre- and post-operative care for a variety of orthopedic-related disorders and sports-related injuries, rehabilitation of injured workers and preventative care. USPh also manages several physical therapy facilities for third parties, including physician groups. Each of USPh's clinics are directed by a licensed physical therapist that drive patient volume via local physicians, former patients and other referral sources. Marketing representatives are used to further augment sales. Historically, USPh has grown its business through de novo development; approximately two-thirds of USPh clinics were originally start-ups. Strategic acquisitions, which accelerate the Company's growth, are structured like the de novo partnerships, with significant ownership retained by founders. " (1/6/2018)

Who are some of U.S. Physical Therapy's key competitors?

Who are U.S. Physical Therapy's key executives?

U.S. Physical Therapy's management team includes the folowing people:

  • Jerald L. Pullins, Independent Chairman of the Board (Age 75)
  • Christopher J. Reading, President, Chief Executive Officer, Director (Age 53)
  • Lawrance W. McAfee, Chief Financial Officer, Executive Vice President, Director (Age 62)
  • Glenn D. McDowell, Chief Operating Officer (Age 60)
  • Reginald E. Swanson, Director (Age 63)
  • Mark J. Brookner, Independent Director (Age 72)
  • Harry S. Chapman, Independent Director (Age 72)
  • Bernard A. Harris Jr., Independent Director (Age 60)
  • Edward L. Kuntz, Independent Director (Age 72)

Who owns U.S. Physical Therapy stock?

U.S. Physical Therapy's stock is owned by a variety of of institutional and retail investors. Top institutional investors include Schwab Charles Investment Management Inc. (0.47%) and Bank of Montreal Can (0.04%). Company insiders that own U.S. Physical Therapy stock include Bernard A Harris Jr, Christopher J Reading, Clayton Trier, Edward L Kuntz, Glenn Mcdowell, Jerald L Pullins, Lawrance W Mcafee, Mark J Brookner and Regg E Swanson. View Institutional Ownership Trends for U.S. Physical Therapy.

Who bought U.S. Physical Therapy stock? Who is buying U.S. Physical Therapy stock?

U.S. Physical Therapy's stock was purchased by a variety of institutional investors in the last quarter, including Schwab Charles Investment Management Inc. and Bank of Montreal Can. View Insider Buying and Selling for U.S. Physical Therapy.

How do I buy U.S. Physical Therapy stock?

Shares of U.S. Physical Therapy can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is U.S. Physical Therapy's stock price today?

One share of U.S. Physical Therapy stock can currently be purchased for approximately $76.80.

How big of a company is U.S. Physical Therapy?

U.S. Physical Therapy has a market capitalization of $957.43 million and generates $356.55 million in revenue each year. The company earns $20.55 million in net income (profit) each year or $1.66 on an earnings per share basis. U.S. Physical Therapy employs 3,800 workers across the globe.

How can I contact U.S. Physical Therapy?

U.S. Physical Therapy's mailing address is 1300 WEST SAM HOUSTON PARKWAY SUITE 300, HOUSTON TX, 77042. The company can be reached via phone at 713-297-7000 or via email at [email protected]


MarketBeat Community Rating for U.S. Physical Therapy (USPH)

Community Ranking:  1.9 out of 5 (star)
Outperform Votes:  127 (Vote Outperform)
Underperform Votes:  211 (Vote Underperform)
Total Votes:  338
MarketBeat's community ratings are surveys of what our community members think about U.S. Physical Therapy and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

U.S. Physical Therapy (NYSE:USPH) Analysts' Consensus Rating

  (How are Consensus Ratings Calculated?)
Today30 Days Ago90 Days Ago180 Days Ago
Consensus Rating: BuyBuyBuyBuy
Consensus Rating Score: 2.502.502.602.50
Ratings Breakdown: 0 Sell Rating(s)
2 Hold Rating(s)
2 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
2 Hold Rating(s)
2 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
2 Hold Rating(s)
3 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
2 Hold Rating(s)
2 Buy Rating(s)
0 Strong Buy Rating(s)
Consensus Price Target: $71.75$70.25$69.75$67.67
Price Target Upside: 0.83% downside2.50% downside17.62% upside8.79% upside

U.S. Physical Therapy (NYSE:USPH) Consensus Price Target History

Price Target History for U.S. Physical Therapy (NYSE:USPH)

U.S. Physical Therapy (NYSE:USPH) Analyst Ratings History

Show:
DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
1/9/2018Cantor FitzgeraldReiterated RatingBuy$80.00LowView Rating Details
11/3/2017Barrington ResearchDowngradeOutperform -> Market PerformN/AView Rating Details
9/8/2017SidotiUpgradeNeutral -> Buy$62.00 -> $74.00LowView Rating Details
8/4/2017Jefferies GroupSet Price TargetHold$65.00LowView Rating Details
11/7/2016JMP SecuritiesReiterated RatingHoldN/AView Rating Details
(Data available from 1/21/2016 forward)

Earnings

U.S. Physical Therapy (NYSE:USPH) Earnings History and Estimates Chart

Earnings by Quarter for U.S. Physical Therapy (NYSE:USPH)

U.S. Physical Therapy (NYSE USPH) Earnings History by Quarter

DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
11/2/2017Q3 2017$0.52$0.48$102.69 million$103.03 millionViewN/AView Earnings Details
8/3/2017Q2 2017$0.60$0.59$102.93 million$104.25 millionViewListenView Earnings Details
6/29/2017Q1 2017$0.49$0.51$97.60 million$97.57 millionViewN/AView Earnings Details
6/7/2017Q4 2016$0.49ViewN/AView Earnings Details
11/3/2016Q316$0.49$0.46$33.94 million$88.30 millionViewN/AView Earnings Details
8/4/2016Q216$0.55$0.57$90.01 million$90.40 millionViewN/AView Earnings Details
5/5/2016Q116$0.39$0.43$83.35 million$86.90 millionViewN/AView Earnings Details
3/3/2016Q4$0.47$0.48$85.47 million$86.72 millionViewN/AView Earnings Details
11/5/2015Q315$0.48$0.47$84.07 million$84.00 millionViewN/AView Earnings Details
8/6/2015Q215$0.58$0.51$84.24 million$83.30 millionViewN/AView Earnings Details
5/7/2015Q115$0.35$0.34$74.74 million$77.24 millionViewN/AView Earnings Details
3/5/2015$0.39$0.41$75.29 million$79.39 millionViewN/AView Earnings Details
11/6/2014Q314$0.42$0.43$75.50 million$77.70 millionViewN/AView Earnings Details
8/7/2014Q214$0.44$0.52$74.25 million$66.90 millionViewN/AView Earnings Details
5/8/2014Q114$0.30$0.35$67.70 million$62.80 millionViewN/AView Earnings Details
3/6/2014Q413$0.35$0.32$65.33 million$62.38 millionViewN/AView Earnings Details
11/7/2013Q313$0.40$0.38$66.32 million$65.83 millionViewN/AView Earnings Details
8/8/2013Q2 2013$0.42$0.41$66.49 million$67.22 millionViewN/AView Earnings Details
5/9/2013Q1 2013$0.33$0.31$62.26 million$63.10 millionViewN/AView Earnings Details
3/7/2013Q4 2012$0.33$0.34$61.99 million$62.70 millionViewN/AView Earnings Details
11/8/2012Q312$0.38$0.38$63.77 million$62.80 millionViewN/AView Earnings Details
8/9/2012$0.44$0.41ViewN/AView Earnings Details
5/3/2012$0.34$0.38ViewN/AView Earnings Details
3/8/2012$0.28$0.29ViewN/AView Earnings Details
11/3/2011$0.35$0.34ViewN/AView Earnings Details
8/4/2011$0.41$0.41ViewN/AView Earnings Details
5/5/2011$0.27$0.31ViewN/AView Earnings Details
3/3/2011$0.25$0.28ViewN/AView Earnings Details
11/4/2010Q3 2010$0.31$0.33ViewN/AView Earnings Details
8/5/2010Q2 2010$0.36$0.38ViewN/AView Earnings Details
5/6/2010Q1 2010$0.23$0.25ViewN/AView Earnings Details
3/4/2010Q4 2009$0.20$0.19ViewN/AView Earnings Details
11/5/2009Q3 2009$0.23$0.26ViewN/AView Earnings Details
8/6/2009Q2 2009$0.24$0.31ViewN/AView Earnings Details
5/7/2009Q1 2009$0.20$0.23ViewN/AView Earnings Details
3/5/2009Q4 2008$0.21$0.19ViewN/AView Earnings Details
11/6/2008Q3 2008$0.22$0.21ViewN/AView Earnings Details
8/7/2008Q2 2008$0.23$0.24ViewN/AView Earnings Details
5/8/2008Q1 2008$0.20$0.20ViewN/AView Earnings Details
3/6/2008Q4 2007$0.19$0.21ViewN/AView Earnings Details
(Earnings results data provided by Zacks Investment Research)

Estimates

U.S. Physical Therapy (NYSE:USPH) Earnings Estimates

Current Year EPS Consensus Estimate: $2.07 EPS
Next Year EPS Consensus Estimate: $2.41 EPS

Dividends

U.S. Physical Therapy (NYSE:USPH) Dividend Information

Most Recent Dividend:12/8/2017
Annual Dividend:$0.80
Dividend Yield:1.04%
Dividend Growth:18.60% (3 Year Average)
Payout Ratio:48.19% (Trailing 12 Months of Earnings)
38.65% (Based on This Year's Estimates)
33.20% (Based on Next Year's Estimates)
Track Record:7 Years of Consecutive Dividend Growth
Frequency:Quarterly Dividend
Dividend Payments by Quarter for U.S. Physical Therapy (NYSE:USPH)

U.S. Physical Therapy (NYSE:USPH) Dividend History by Quarter

AnnouncedPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
10/31/2017Quarterly$0.201.21%11/16/201711/17/201712/8/2017
8/3/2017quarterly$0.201.27%8/17/20178/21/20179/8/2017
5/31/2017Quarterly$0.201.25%6/14/20176/16/20177/7/2017
4/3/2017quarterly$0.201.25%4/12/20174/17/20175/5/2017
11/3/2016quarterly$0.171.28%11/16/201611/18/201612/2/2016
8/4/2016quarterly$0.171.12%8/17/20168/19/20169/2/2016
5/5/2016quarterly$0.171.31%5/13/20165/17/20166/3/2016
3/4/2016quarterly$0.171.33%3/16/20163/18/20164/1/2016
11/6/2015quarterly$0.151.15%11/13/201511/17/201512/4/2015
8/7/2015quarterly$0.151.18%8/14/20158/18/20159/4/2015
5/7/2015quarterly$0.151.24%5/14/20155/18/20156/5/2015
3/6/2015quarterly$0.151.33%3/18/20153/20/20154/3/2015
11/6/2014quarterly$0.121.23%11/13/201411/17/201412/5/2014
8/7/2014quarterly$0.121.32%8/14/20148/18/20149/5/2014
5/8/2014quarterly$0.121.54%5/16/20145/20/20146/6/2014
3/7/2014quarterly$0.121.48%3/17/20143/19/20144/4/2014
11/7/2013quarterly$0.101.36%11/13/201311/15/201312/6/2013
8/8/2013quarterly$0.101.28%8/16/20138/20/20139/6/2013
5/9/2013quarterly$0.101.59%5/15/20135/17/20136/7/2013
3/7/2013quarterly$0.101.71%3/13/20133/15/20133/29/2013
(Data available from 1/1/2013 forward)

Insider Trades

U.S. Physical Therapy (NYSE USPH) Insider Trading and Institutional Ownership History

Insider Ownership Percentage: 3.10%
Institutional Ownership Percentage: 94.12%
Insider Trades by Quarter for U.S. Physical Therapy (NYSE:USPH)
Institutional Ownership by Quarter for U.S. Physical Therapy (NYSE:USPH)

U.S. Physical Therapy (NYSE USPH) Insider Trades by Quarter

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
12/27/2017Mark J. BrooknerDirectorSell2,625$71.23$186,978.75View SEC Filing  
12/12/2017Clayton TrierDirectorSell4,250$71.97$305,872.50View SEC Filing  
12/12/2017Lawrance W. McafeeCFOSell2,000$72.56$145,120.00View SEC Filing  
11/16/2017Lawrance W. McafeeCFOSell2,000$68.68$137,360.00View SEC Filing  
11/8/2017Christopher J. ReadingCEOSell15,000$66.52$997,800.00View SEC Filing  
11/8/2017Lawrance W. McafeeCFOSell5,200$66.37$345,124.00View SEC Filing  
11/3/2017Lawrance W. McafeeCFOSell800$69.21$55,368.00View SEC Filing  
8/30/2017Glenn McdowellCOOSell2,598$57.00$148,086.00View SEC Filing  
8/29/2017Glenn McdowellCOOSell1,004$57.01$57,238.04View SEC Filing  
8/22/2017Glenn McdowellCOOSell1,664$59.91$99,690.24View SEC Filing  
8/11/2017Lawrance W. McafeeCFOSell3,000$62.04$186,120.00View SEC Filing  
8/10/2017Bernard A Harris JrDirectorSell5,000$62.00$310,000.0026,422View SEC Filing  
12/9/2016Edward L. KuntzDirectorSell2,500$68.40$171,000.00View SEC Filing  
11/22/2016Lawrance W. McafeeCFOSell2,000$62.55$125,100.00View SEC Filing  
11/15/2016Glenn McdowellCOOSell4,047$61.15$247,474.05View SEC Filing  
11/10/2016Lawrance W. McafeeCFOSell2,000$58.04$116,080.00View SEC Filing  
9/19/2016Christopher J. ReadingCEOSell8,000$64.01$512,080.00View SEC Filing  
9/19/2016Lawrance W. McafeeCFOSell2,000$64.00$128,000.00View SEC Filing  
8/25/2016Lawrance W. McafeeCFOSell2,000$62.50$125,000.00View SEC Filing  
8/9/2016Glenn McdowellCOOSell4,047$60.20$243,629.40View SEC Filing  
8/5/2016Lawrance W. McafeeCFOSell2,000$59.60$119,200.00View SEC Filing  
6/10/2016Lawrance W McafeeCFOSell2,000$59.27$118,540.0039,212View SEC Filing  
5/20/2016Regg E SwansonDirectorSell3,000$57.29$171,870.00View SEC Filing  
5/11/2016Bernard A Harris JrDirectorSell3,000$58.10$174,300.0031,834View SEC Filing  
5/9/2016Glenn McdowellCOOSell8,354$57.95$484,114.3034,417View SEC Filing  
5/9/2016Lawrance W McafeeCFOSell4,000$54.90$219,600.0043,212View SEC Filing  
3/14/2016Jerald L PullinsDirectorSell5,000$51.35$256,750.0024,596View SEC Filing  
3/4/2016Lawrance W McafeeCFOSell5,000$52.74$263,700.0045,212View SEC Filing  
12/29/2015Clayton TrierDirectorSell4,500$55.23$248,535.0011,250View SEC Filing  
12/16/2015Lawrance W McafeeCFOSell4,000$51.24$204,960.0038,852View SEC Filing  
11/20/2015Christopher J. ReadingCEOSell25,000$52.12$1,303,000.0094,157View SEC Filing  
11/11/2015Glenn McdowellCOOSell4,299$51.25$220,323.7531,411View SEC Filing  
11/6/2015Lawrance W McafeeCFOSell4,000$51.00$204,000.0042,852View SEC Filing  
8/25/2015Lawrance W McafeeCFOSell2,000$47.06$94,120.0046,852View SEC Filing  
8/24/2015Harry S ChapmanDirectorBuy1,000$46.90$46,900.0033,750View SEC Filing  
8/18/2015Regg E SwansonDirectorSell2,000$51.68$103,360.00View SEC Filing  
3/20/2015Lawrance W McafeeCFOSell2,350$48.25$113,387.50View SEC Filing  
3/19/2015Christopher J ReadingCEOSell22,600$48.12$1,087,512.00View SEC Filing  
3/17/2015Glenn McdowellCOOSell2,299$47.92$110,168.08View SEC Filing  
3/16/2015Christopher J ReadingCEOSell2,400$49.29$118,296.00View SEC Filing  
3/16/2015Glenn McdowellCOOSell2,000$49.13$98,260.00View SEC Filing  
3/16/2015Lawrance W McafeeCFOSell2,650$49.07$130,035.50View SEC Filing  
3/9/2015Clayton TrierDirectorSell3,250$45.05$146,412.50View SEC Filing  
3/6/2015Lawrance W McafeeCFOSell10,000$45.34$453,400.00View SEC Filing  
12/5/2014Glenn McdowellCOOSell19,621$39.95$783,858.95View SEC Filing  
12/2/2014Clayton TrierDirectorSell3,250$39.49$128,342.50View SEC Filing  
11/28/2014Christopher J ReadingCEOSell9,759$39.29$383,431.11View SEC Filing  
11/25/2014Christopher J ReadingCEOSell10,241$39.00$399,399.00View SEC Filing  
11/11/2014Clayton TrierDirectorSell1,002$39.83$39,909.66View SEC Filing  
11/7/2014Lawrance W McafeeCFOSell10,000$39.23$392,300.00View SEC Filing  
9/5/2014Mark J BrooknerDirectorSell3,105$35.80$111,159.00View SEC Filing  
9/3/2014Mark J BrooknerDirectorSell549$35.82$19,665.18View SEC Filing  
9/2/2014Jerald L PullinsDirectorSell3,000$35.46$106,380.00View SEC Filing  
8/29/2014Mark J BrooknerDirectorSell96$35.75$3,432.00View SEC Filing  
8/27/2014Jerald L PullinsDirectorSell3,000$35.86$107,580.00View SEC Filing  
8/8/2014Lawrance W McafeeCFOSell5,000$34.55$172,750.00View SEC Filing  
3/28/2014Jerald PullinsDirectorSell6,000$32.92$197,520.0035,846View SEC Filing  
3/12/2014Jerald PullinsDirectorSell7,000$32.98$230,860.0041,846View SEC Filing  
3/7/2014Lawrance McafeeCFOSell10,000$32.07$320,700.0060,852View SEC Filing  
11/22/2013Lawrance McafeeCFOSell5,000$33.02$165,100.0055,852View SEC Filing  
11/11/2013Harry ChapmanDirectorBuy1,750$30.18$52,815.0026,750View SEC Filing  
11/8/2013Lawrance McafeeCFOSell5,000$29.71$148,550.0060,852View SEC Filing  
9/4/2013Glenn McdowellCOOSell11,148$28.54$318,163.9233,228View SEC Filing  
8/9/2013Lawrance McafeeCFOSell10,000$29.81$298,100.0065,852View SEC Filing  
6/13/2013Christopher J ReadingCEOSell20,000$29.05$581,000.00View SEC Filing  
6/10/2013Lawrance W McafeeCFOSell5,000$29.18$145,900.00View SEC Filing  
5/28/2013Clayton TrierDirectorSell6,500$28.35$184,275.00View SEC Filing  
5/10/2013Lawrance W McafeeCFOSell5,000$24.55$122,750.00View SEC Filing  
12/12/2012Harry S ChapmanDirectorBuy1,200$27.02$32,424.00View SEC Filing  
(Data available from 1/1/2013 forward)

Headlines

U.S. Physical Therapy (NYSE USPH) News Headlines

Source:
DateHeadline
U.S. Physical Therapy, Inc. (USPH) Given Average Recommendation of "Buy" by BrokeragesU.S. Physical Therapy, Inc. (USPH) Given Average Recommendation of "Buy" by Brokerages
www.americanbankingnews.com - January 15 at 1:38 AM
U.S. Physical Therapy Reports Preliminary Estimated 2018 Effective Tax RateU.S. Physical Therapy Reports Preliminary Estimated 2018 Effective Tax Rate
finance.yahoo.com - January 10 at 10:36 AM
Zacks: Analysts Expect U.S. Physical Therapy, Inc. (USPH) Will Announce Quarterly Sales of $106.49 MillionZacks: Analysts Expect U.S. Physical Therapy, Inc. (USPH) Will Announce Quarterly Sales of $106.49 Million
www.americanbankingnews.com - January 7 at 6:26 PM
U.S. Physical Therapy (USPH) Raised to "Buy" at Zacks Investment ResearchU.S. Physical Therapy (USPH) Raised to "Buy" at Zacks Investment Research
www.americanbankingnews.com - January 6 at 10:20 AM
Insider Selling: U.S. Physical Therapy, Inc. (USPH) Director Sells 2,625 Shares of StockInsider Selling: U.S. Physical Therapy, Inc. (USPH) Director Sells 2,625 Shares of Stock
www.americanbankingnews.com - December 28 at 6:58 PM
U.S. Physical Therapy, Inc. (USPH) Expected to Announce Quarterly Sales of $106.49 MillionU.S. Physical Therapy, Inc. (USPH) Expected to Announce Quarterly Sales of $106.49 Million
www.americanbankingnews.com - December 21 at 7:28 AM
U.S. Physical Therapy, Inc. (USPH) Given Consensus Recommendation of "Hold" by BrokeragesU.S. Physical Therapy, Inc. (USPH) Given Consensus Recommendation of "Hold" by Brokerages
www.americanbankingnews.com - December 21 at 1:38 AM
U.S. Physical Therapy, Inc. (USPH) Expected to Announce Earnings of $0.48 Per ShareU.S. Physical Therapy, Inc. (USPH) Expected to Announce Earnings of $0.48 Per Share
www.americanbankingnews.com - December 19 at 11:22 AM
U.S. Physical Therapy (USPH) versus Its Rivals Critical ReviewU.S. Physical Therapy (USPH) versus Its Rivals Critical Review
www.americanbankingnews.com - December 17 at 5:34 PM
Analyzing U.S. Physical Therapy (USPH) and Its RivalsAnalyzing U.S. Physical Therapy (USPH) and Its Rivals
www.americanbankingnews.com - December 17 at 3:20 PM
Analyzing U.S. Physical Therapy (USPH) and Its CompetitorsAnalyzing U.S. Physical Therapy (USPH) and Its Competitors
www.americanbankingnews.com - December 16 at 11:10 PM
Critical Survey: U.S. Physical Therapy (USPH) & Its PeersCritical Survey: U.S. Physical Therapy (USPH) & Its Peers
www.americanbankingnews.com - December 16 at 7:28 PM
U.S. Physical Therapy (USPH) versus Its Competitors Head-To-Head AnalysisU.S. Physical Therapy (USPH) versus Its Competitors Head-To-Head Analysis
www.americanbankingnews.com - December 15 at 11:16 PM
U.S. Physical Therapy (USPH) & The Competition Head to Head SurveyU.S. Physical Therapy (USPH) & The Competition Head to Head Survey
www.americanbankingnews.com - December 15 at 3:32 PM
Comparing U.S. Physical Therapy (USPH) and Its CompetitorsComparing U.S. Physical Therapy (USPH) and Its Competitors
www.americanbankingnews.com - December 15 at 1:34 PM
Comparing U.S. Physical Therapy (USPH) & Its PeersComparing U.S. Physical Therapy (USPH) & Its Peers
www.americanbankingnews.com - December 14 at 11:04 PM
U.S. Physical Therapy (USPH) & Its Peers Head to Head ComparisonU.S. Physical Therapy (USPH) & Its Peers Head to Head Comparison
www.americanbankingnews.com - December 14 at 7:50 PM
Financial Review: U.S. Physical Therapy (USPH) versus The CompetitionFinancial Review: U.S. Physical Therapy (USPH) versus The Competition
www.americanbankingnews.com - December 13 at 3:53 PM
U.S. Physical Therapy (USPH) versus Its Peers Critical ContrastU.S. Physical Therapy (USPH) versus Its Peers Critical Contrast
www.americanbankingnews.com - December 13 at 3:53 PM
U.S. Physical Therapy, Inc. (USPH) CFO Lawrance W. Mcafee Sells 2,000 SharesU.S. Physical Therapy, Inc. (USPH) CFO Lawrance W. Mcafee Sells 2,000 Shares
www.americanbankingnews.com - December 13 at 2:34 PM
Reviewing U.S. Physical Therapy (USPH) and The CompetitionReviewing U.S. Physical Therapy (USPH) and The Competition
www.americanbankingnews.com - December 12 at 9:34 PM
Contrasting U.S. Physical Therapy (USPH) & Its CompetitorsContrasting U.S. Physical Therapy (USPH) & Its Competitors
www.americanbankingnews.com - December 12 at 7:34 PM
Clayton Trier Sells 4,250 Shares of U.S. Physical Therapy, Inc. (USPH) StockClayton Trier Sells 4,250 Shares of U.S. Physical Therapy, Inc. (USPH) Stock
www.americanbankingnews.com - December 12 at 6:06 PM
U.S. Physical Therapy (USPH) versus Its Competitors Head to Head ReviewU.S. Physical Therapy (USPH) versus Its Competitors Head to Head Review
www.americanbankingnews.com - December 12 at 9:26 AM
Update in Lawsuit for Investors in U.S. Physical Therapy, Inc. (NYSE: USPH) Shares Announced by Shareholders FoundationUpdate in Lawsuit for Investors in U.S. Physical Therapy, Inc. (NYSE: USPH) Shares Announced by Shareholders Foundation
finance.yahoo.com - December 11 at 11:14 AM
U.S. Physical Therapy (USPH) & Its Rivals Critical ReviewU.S. Physical Therapy (USPH) & Its Rivals Critical Review
www.americanbankingnews.com - December 11 at 5:38 AM
U.S. Physical Therapy (USPH) vs. Its Peers Financial AnalysisU.S. Physical Therapy (USPH) vs. Its Peers Financial Analysis
www.americanbankingnews.com - December 8 at 1:30 AM
U.S. Physical Therapy (USPH) and Its Peers Financial SurveyU.S. Physical Therapy (USPH) and Its Peers Financial Survey
www.americanbankingnews.com - December 6 at 8:04 AM
U.S. Physical Therapy (USPH) and Its Rivals Financial SurveyU.S. Physical Therapy (USPH) and Its Rivals Financial Survey
www.americanbankingnews.com - December 6 at 5:36 AM
Reviewing U.S. Physical Therapy (USPH) and Its RivalsReviewing U.S. Physical Therapy (USPH) and Its Rivals
www.americanbankingnews.com - December 1 at 11:36 PM
 Analysts Expect U.S. Physical Therapy, Inc. (USPH) to Post $0.48 Earnings Per Share Analysts Expect U.S. Physical Therapy, Inc. (USPH) to Post $0.48 Earnings Per Share
www.americanbankingnews.com - December 1 at 7:30 PM
Head to Head Contrast: U.S. Physical Therapy (USPH) & Its CompetitorsHead to Head Contrast: U.S. Physical Therapy (USPH) & Its Competitors
www.americanbankingnews.com - December 1 at 11:38 AM
Comparing U.S. Physical Therapy (USPH) and The CompetitionComparing U.S. Physical Therapy (USPH) and The Competition
www.americanbankingnews.com - December 1 at 5:39 AM
ETFs with exposure to U.S. Physical Therapy, Inc. : November 27, 2017ETFs with exposure to U.S. Physical Therapy, Inc. : November 27, 2017
finance.yahoo.com - November 28 at 11:36 AM
U.S. Physical Therapy (USPH) vs. Its Competitors Head-To-Head ContrastU.S. Physical Therapy (USPH) vs. Its Competitors Head-To-Head Contrast
www.americanbankingnews.com - November 27 at 7:08 PM
U.S. Physical Therapy (USPH) & Its Competitors Critical ReviewU.S. Physical Therapy (USPH) & Its Competitors Critical Review
www.americanbankingnews.com - November 26 at 1:30 PM
U.S. Physical Therapy, Inc. (USPH) Given Average Rating of "Hold" by BrokeragesU.S. Physical Therapy, Inc. (USPH) Given Average Rating of "Hold" by Brokerages
www.americanbankingnews.com - November 26 at 1:38 AM
Head-To-Head Contrast: U.S. Physical Therapy (USPH) versus Its CompetitorsHead-To-Head Contrast: U.S. Physical Therapy (USPH) versus Its Competitors
www.americanbankingnews.com - November 25 at 1:16 PM
U.S. Physical Therapy, Inc. :USPH-US: Earnings Analysis: Q3, 2017 By the Numbers : November 22, 2017U.S. Physical Therapy, Inc. :USPH-US: Earnings Analysis: Q3, 2017 By the Numbers : November 22, 2017
finance.yahoo.com - November 22 at 3:40 PM
Analyzing U.S. Physical Therapy (USPH) & Its RivalsAnalyzing U.S. Physical Therapy (USPH) & Its Rivals
www.americanbankingnews.com - November 22 at 1:12 AM
U.S. Physical Therapy (USPH) and Its Rivals Critical AnalysisU.S. Physical Therapy (USPH) and Its Rivals Critical Analysis
www.americanbankingnews.com - November 21 at 1:22 AM
Lawrance W. Mcafee Sells 2,000 Shares of U.S. Physical Therapy, Inc. (USPH) StockLawrance W. Mcafee Sells 2,000 Shares of U.S. Physical Therapy, Inc. (USPH) Stock
www.americanbankingnews.com - November 17 at 1:48 PM
U.S. Physical Therapy, Inc. (USPH) Expected to Post Quarterly Sales of $105.83 MillionU.S. Physical Therapy, Inc. (USPH) Expected to Post Quarterly Sales of $105.83 Million
www.americanbankingnews.com - November 14 at 3:10 AM
U.S. Physical Therapy renews $125M credit lineU.S. Physical Therapy renews $125M credit line
seekingalpha.com - November 12 at 1:01 PM
U.S. Physical Therapy, Inc. (USPH) Plans $0.20 Quarterly DividendU.S. Physical Therapy, Inc. (USPH) Plans $0.20 Quarterly Dividend
www.americanbankingnews.com - November 11 at 10:22 AM
U.S. Physical Therapy, Inc. (USPH) CEO Christopher J. Reading Sells 15,000 SharesU.S. Physical Therapy, Inc. (USPH) CEO Christopher J. Reading Sells 15,000 Shares
www.americanbankingnews.com - November 9 at 3:30 PM
U.S. Physical Therapy, Inc. (USPH) CFO Lawrance W. Mcafee Sells 5,200 SharesU.S. Physical Therapy, Inc. (USPH) CFO Lawrance W. Mcafee Sells 5,200 Shares
www.americanbankingnews.com - November 9 at 3:28 PM
Reviewing <html id= (VHS) and U.S. Physical Therapy (USPH)Reviewing
www.americanbankingnews.com - November 8 at 9:31 AM
Insider Selling: U.S. Physical Therapy, Inc. (USPH) CFO Sells 800 Shares of StockInsider Selling: U.S. Physical Therapy, Inc. (USPH) CFO Sells 800 Shares of Stock
www.americanbankingnews.com - November 7 at 3:36 PM
U.S. Physical Therapy, Inc. (USPH) Lowered to Market Perform at Barrington ResearchU.S. Physical Therapy, Inc. (USPH) Lowered to Market Perform at Barrington Research
www.americanbankingnews.com - November 5 at 4:56 PM

SEC Filings

U.S. Physical Therapy (NYSE:USPH) SEC Filings

This page is loading this company's SEC Filings. Please wait...

Social Media

Financials

U.S. Physical Therapy (NYSE:USPH) Income Statement, Balance Sheet and Cash Flow Statement

Chart

U.S. Physical Therapy (NYSE USPH) Stock Chart for Sunday, January, 21, 2018

Loading chart…

This page was last updated on 1/21/2018 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.